Announcement.
M-SAN HQ Now Available in GMP Grade
L E A R N   M O R E
Enzymes that Unlock
Your Next Discovery
0
Resources
Company
Contact
X

Essential insights based on 3rd party publications:

Get the White Paper now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X

Quantification Challenges of Chromatin — Associated Host Cell DNA:
An Underestimated Risk

  • Discover why host cell DNA quantities are often significantly underestimated.
  • Understand the limitation of conventional nucleases when degrading chromatin

Download the poster here
and get access to the
interactive Q&A

Get the Poster now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Investors News

ArcticZymes Technologies ASA Q4 2023 Results & Presentation

Feb 1, 2024

Tromsø, Norway, February 1st, 2024 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 28.4 million and an EBITDA of NOK 2.0 million for the fourth quarter of 2023.

Read More
Read More

New Product Launch - SAN HQ GMP

Jan 30, 2024

Tromsø, Norway, January 30th, 2024 – ArcticZymes Technologies ASA (OSE:AZT) announces the launch of Salt Active Nuclease High Quality GMP Grade (SAN HQ GMP).

Read More
Read More

ArcticZymes Technologies launches T7 RNA Polymerase

Dec 21, 2023

Tromsø, Norway, December 21, 2023 – ArcticZymes Technologies ASA (OSE: AZT) announced the launch of its new product, T7 RNA Polymerase. The T7 RNA Polymerase, specifically designed for molecular research and diagnostics, caters to the specialized needs of our customers in the Molecular Tools segment.

Read More
Read More

ArcticZymes Technologies Announces Partnership with Biomatter

Dec 19, 2023

Tromsø, Norway, December 19, 2023 – ArcticZymes Technologies ASA (OSE: AZT) enters an agreement with Biomatter (Biomatter Designs UAB) to develop new enzyme-based products.

Read More
Read More